Royalty Pharma to provide up to $500 million, including $75 million for Phase 2b funding and a Royalty Pharma option for an additional $425 million to support Teva’s anti-IL-15 candidate TEV-‘408 TEV- ...
Once you reach a certain age, you may find yourself reaching for the bread basket less often. While any food can fit into an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback